Navigation Links
Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues
Date:8/15/2008

The Drug Information Association (DIA), in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the 2nd Conference on Oligonucleotide-based Therapeutics (September 22 - 24; Falls Church, VA).

Horsham, PA (PRWEB) August 15, 2008 -- The http://www.diahome.org/ [Drug Information Association (DIA)]], in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=14730&eventType=Meeting [2nd Conference on Oligonucleotide-based Therapeutics] (September 22 - 24; Falls Church, VA).

"Attendees can share product development and regulatory information in the areas of nonclinical, chemistry, manufacturing and control (CMC), and clinical development of Oligonucleotide-based therapeutic drugs with industry experts and international regulators," says Program Co-chair David H. Schubert, Vice President of Regulatory Affairs, Logical Therapeutics, Inc.

Sessions will discuss:

  • siRNAs
  • Non-Hybridization Dependent Oligonucleotides
  • Antisense Oligonucleotide Discovery and Development
  • Emerging Oligonucleotide Issues
  • Starting Materials and GMP Synthesis
  • Formulations and GMP
  • Establishing Proof of Structure
  • Stability of Drug Substance and Drug Product
  • Novel Chemistry
  • Clinical Applications of siRNAs
  • Clinical Opportunities for Manipulating MicroRNAs Pathways
  • Clinical applications of Antisense Oligonucleotides
  • Clinical Applications of Aptamers
  • Clinical Opportunities for Immunostimulatory Oligonucleotides
  • Delivery of Oligonucleotides

Keynote speakers will include Craig C. Mello, PhD, University of Mass Medical School and 2006 Nobel Laureate, and Alan B. Sachs, MD, PhD, Merck Research Laboratories.

The final day will feature a panel discussion with representatives from the EMEA, FDA, Health Canada and PMDA.

About the www.diahome.org [Drug Information Association (DIA)]
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
215-293-5812
Joe.Krasowski @ diahome.org

# # #

Read the full story at http://www.prweb.com/releases/Oligonucleotide-Based/Therapeutics/prweb1213554.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter 2008 Earnings Results
2. ChemBridge Research Laboratories, Inc. (CRL) has Established an Industry Record and Benchmark in Hit-to-Lead Libraries Turn-around Time
3. Anthem Blue Cross and Blue Shield in Colorado Introduces Industry Leading and Comprehensive Transparency Initiative to Colorado
4. Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications
5. REHACARE INTERNATIONAL 2008: Platform for Rehabilitation Industry
6. Southern Home Medicals Encore Medical Staffing Division Poised to Benefit from Major Growth in Nursing Industry
7. R&D and Regulatory Leaders in the Cosmetics/Personal Care Field Present Latest Industry Research at HBA Global Expo
8. Eularis Analyzes Most Effective Generics Defense Strategies With New Pharmaceutical Industry Report
9. Entertainment Industry Foundation Unites Major Studios and State of California for Historic Anti-Smoking Campaign
10. Advisory: Entertainment Industry Foundation, Gov. Schwarzenegger to Announce Major Hollywood Anti-Smoking Initiative
11. Lilly Supports Industry Code on Interactions with Healthcare Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: